{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:25:53Z","timestamp":1790623553709,"version":"4.1.0"},"reference-count":24,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":467,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1111\/bcp.12264","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T23:34:34Z","timestamp":1383003274000},"page":"1011-1016","source":"Crossref","is-referenced-by-count":48,"title":["The absolute bioavailability of racemic ketamine from a novel sublingual formulation"],"prefix":"10.1111","volume":"77","author":[{"given":"Paul","family":"Rolan","sequence":"first","affiliation":[{"name":"Discipline of Pharmacology; School of Medical Sciences; University of Adelaide; Adelaide SA 5005 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lim","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Curtin Health Innovation Research Institute; Curtin University; Perth WA 6854 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Sunderland","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Curtin Health Innovation Research Institute; Curtin University; Perth WA 6854 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandi","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Curtin Health Innovation Research Institute; Curtin University; Perth WA 6854 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Molnar","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Consulting; Adelaide SA 5066 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,22]]},"reference":[{"key":"10.1111\/bcp.12264-BIB0001|bcp12264-cit-0001","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12094","article-title":"Ketamine for chronic pain: risks and benefits","volume":"77","author":"Niesters","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/bcp.12264-BIB0002|bcp12264-cit-0002","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pain.2004.09.036","article-title":"Ketamine and postoperative pain - a quantitative systematic review of randomised trials","volume":"113","author":"Elia","year":"2005","journal-title":"Pain"},{"issue":"1","key":"10.1111\/bcp.12264-BIB0003|bcp12264-cit-0003","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004603.pub2","article-title":"Perioperative ketamine for acute postoperative pain","author":"Bell","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bcp.12264-BIB0004|bcp12264-cit-0004","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/cns.12111","article-title":"Ketamine in pain management","volume":"19","author":"Persson","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.1111\/bcp.12264-BIB0005|bcp12264-cit-0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.biopha.2006.06.021","article-title":"The role of ketamine in pain management","volume":"60","author":"Visser","year":"2006","journal-title":"Biomed Pharmacother"},{"key":"10.1111\/bcp.12264-BIB0006|bcp12264-cit-0006","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0028-3908(85)90128-5","article-title":"Ketamine acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in vitro","volume":"24","author":"Martin","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1111\/bcp.12264-BIB0007|bcp12264-cit-0007","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.neuropharm.2005.11.019","article-title":"Effects of ketamine on acute somatic nociception in wild-type and N-methyl-D-aspartate (NMDA) receptor e1 subunit knockout mice","volume":"50","author":"Petrenko","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1111\/bcp.12264-BIB0008|bcp12264-cit-0008","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/npp.2011.155","article-title":"The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control","volume":"37","author":"Rodriguez-Munoz","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/bcp.12264-BIB0009|bcp12264-cit-0009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuroimage.2012.09.037","article-title":"Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers","volume":"64","author":"Simoni","year":"2013","journal-title":"NeuroImage"},{"key":"10.1111\/bcp.12264-BIB0010|bcp12264-cit-0010","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1399-6576.2011.02446.x","article-title":"Ketamine as an analgesic in the pre-hospital setting: a systematic review","volume":"55","author":"Jennings","year":"2011","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1111\/bcp.12264-BIB0011|bcp12264-cit-0011","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/14656566.2011.521743","article-title":"Adjuvant analgesics in acute pain","volume":"12","author":"Lui","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/bcp.12264-BIB0012|bcp12264-cit-0012","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pain.2003.07.001","article-title":"Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study","volume":"108","author":"Carr","year":"2004","journal-title":"Pain"},{"key":"10.1111\/bcp.12264-BIB0013|bcp12264-cit-0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-2999(78)90217-0","article-title":"Comparative pharmacology of the optical isomers of ketamine","volume":"49","author":"Ryder","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/bcp.12264-BIB0014|bcp12264-cit-0014","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/00000542-199912000-00027","article-title":"Ketamine distribution described by a recirculatory pharmacokinetic model is not stereoselective","volume":"91","author":"Henthorn","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1111\/bcp.12264-BIB0015|bcp12264-cit-0015","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/bja\/70.6.666","article-title":"Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method","volume":"70","author":"Geisslinger","year":"1993","journal-title":"Br J Anaesth"},{"key":"10.1111\/bcp.12264-BIB0016|bcp12264-cit-0016","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/ALN.0b013e3181b437b1","article-title":"S(+)-ketamine effect on experimental pain and cardiac output","volume":"111","author":"Sigtermans","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1111\/bcp.12264-BIB0017|bcp12264-cit-0017","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000542-199212000-00022","article-title":"Metabolism of ketamine stereoisomers by human liver microsomes","volume":"77","author":"Kharasch","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1111\/bcp.12264-BIB0018|bcp12264-cit-0018","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1124\/dmd.30.7.853","article-title":"Contribution of CYP3A4, CP2B6 and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes","volume":"30","author":"Hijazi","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/bcp.12264-BIB0019|bcp12264-cit-0019","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/ALN.0b013e31825b6c91","article-title":"Estimation of the contribution of norketamine to ketamine-induced acute pain relief and neurocognitive impairment in healthy volunteers","volume":"117","author":"Olofsen","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1111\/bcp.12264-BIB0020|bcp12264-cit-0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdd.336","article-title":"Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers","volume":"24","author":"Yanagihara","year":"2003","journal-title":"Biopharm Drug Dispos"},{"key":"10.1111\/bcp.12264-BIB0021|bcp12264-cit-0021","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00044011-200929050-00004","article-title":"Development of a sublingual\/oral formulation of ketamine for use in neuropathic pain","volume":"29","author":"Chong","year":"2009","journal-title":"Clin Drug Investig"},{"key":"10.1111\/bcp.12264-BIB0022|bcp12264-cit-0022","unstructured":"World Medical Association (WMA) Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects 2000 http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/index.html"},{"key":"10.1111\/bcp.12264-BIB0023|bcp12264-cit-0023","unstructured":"European Agency for the Evaluation of Medicinal Products (EMEA) International Conference on Harmonisation-World Health Organization. Guideline for Good Clinical Practice http:\/\/www.ema.europa.eu\/pdfs\/human\/ich\/013595en.pdf"},{"key":"10.1111\/bcp.12264-BIB0024|bcp12264-cit-0024","first-page":"82","article-title":"Development of a sensitive assay for the quantification of (S)-ketamine in plasma using HPLC with UV detection","volume":"9","author":"Menelaou","year":"2001","journal-title":"Proc Aust Soc Clin Exp Pharmacol Toxicol"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.12264","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bcp.12264\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T09:47:41Z","timestamp":1625392061000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bcp.12264"}},"subtitle":["Bioavailability of sublingual ketamine"],"short-title":[],"issued":{"date-parts":[[2014,5,22]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1111\/bcp.12264","relation":{},"ISSN":["0306-5251"],"issn-type":[{"value":"0306-5251","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,22]]}}}